Hasil Pencarian - A. Zwerling

  • Menampilkan 1 - 7 hasil dari 7
Perbaiki Hasil
  1. 1
    Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review

    Tuberculosis screening costs and cost-effectiveness in high-risk groups: a systematic review oleh H. Alsdurf, B. Empringham, C. Miller, A. Zwerling

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review

    Cost-effectiveness of 3-months isoniazid and rifapentine compared to 9-months isoniazid for latent tuberculosis infection: a systematic review oleh Wendy A. Lai, Kaitlyn Brethour, Olivia D’Silva, Richard E. Chaisson, Alice A. Zwerling

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis

    Measuring Stigma to Assess the Social Justice Implications of Health-Related Policy Decisions: Application to Novel Treatment Regimens for Multidrug-Resistant Tuberculosis oleh David W. Dowdy, Alice A. Zwerling, Andrea Stennett, Alexandra Searle, Vadim Dukhanin, Holly A. Taylor, Maria W. Merritt

    Diterbitkan 2020-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country

    Seven-year retrospective study understanding the latent TB infection treatment cascade of care among adults in a low incidence country oleh K. Sullivan, C. Pease, A. Zwerling, R. Mallick, D. Van Dyk, S. Mulpuru, C. Allen, H. Alsdurf, G. G. Alvarez

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB)

    Disadvantage and the experience of treatment for multidrug-resistant tuberculosis (MDR-TB) oleh Holly A. Taylor, David W. Dowdy, Alexandra R. Searle, Andrea L. Stennett, Vadim Dukhanin, Alice A. Zwerling, Maria W. Merritt

    Diterbitkan 2022-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study

    The implementation of rifapentine and isoniazid (3HP) in two remote Arctic communities with a predominantly Inuit population, the Taima TB 3HP study oleh G. G. Alvarez, D. Van Dyk, R. Mallick, S. Lesperance, P. Demaio, S. Finn, S. Edmunds Potvin, M. Patterson, C. Pease, K. Amaratunga, C. Hui, D.W. Cameron, S. Mulpuru, S.D. Aaron, F. Momoli, A. Zwerling

    Diterbitkan 2020-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series design

    Effect of implementation of a 12-dose once-weekly treatment (3HP) in addition to standard regimens to prevent TB on completion rates: Interrupted time series design oleh Gonzalo G. Alvarez, Kathryn Sullivan, Christopher Pease, Deborah Van Dyk, Ranjeeta Mallick, Monica Taljaard, Jeremy M. Grimshaw, Kanchana Amaratunga, Crystal Allen, Kaitlyn Brethour, Sunita Mulpuru, Smita Pakhale, Shawn D. Aaron, D. William Cameron, Hannah Alsdurf, Charles Hui, Alice A. Zwerling

    Diterbitkan 2022-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: